|
Real-time Estimate
Cboe BZX
10:48:42 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 14.26 USD | -1.01% |
|
-11.56% | - |
| 10-22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-20 | Drug developer Lycia Therapeutics targets $938 million valuation in US IPO | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 683M | - | - | - | - | - |
| 65.28B | |||||
| 54.57B | |||||
| 53.59B | |||||
| 45.03B | |||||
| 42.17B |
Select your edition
All financial news and data tailored to specific country editions
